An immunoassay (enzyme-linked immunosorbent assay - ELISA) is used for the qualitative detection of IgG antibodies against hepatitis C virus (HCV) in serum or blood plasma. The presence of these antibodies indicates past or present exposure of the immune system to the virus, but it does not differentiate between current active infection and infection that has been cleared (recovered).